Sebastien Maloveste

Corporate Officer/Principal chez NEXTCURE, INC.

Health Technology

Consumer Services

Postes actifs de Sebastien Maloveste

Sociétés	Poste	Début	Fin
NEXTCURE, INC.	Corporate Officer/Principal	-	-

Sociétés	Poste	Début	Fin
Amplimmune, Inc. Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.	Corporate Officer/Principal	-	-
GENVEC INC	Corporate Officer/Principal	01/01/2015	-

Universite De La Mediterranee

Doctorate Degree

Internationale

Etats-Unis	4
France	2

Opérationnelle

Corporate Officer/Principal	3
Doctorate Degree	1

Sectorielle

Health Technology	4
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
NEXTCURE, INC.	Health Technology

Entreprise privées	2
GenVec, Inc. GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD.	Health Technology
Amplimmune, Inc. Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.	Health Technology

Entreprise privées

Health Technology